UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059404
Receipt number R000067890
Scientific Title Treatment strategies of colorectal liver metastases
Date of disclosure of the study information 2025/10/15
Last modified on 2025/10/15 00:08:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment strategies of colorectal liver metastases

Acronym

Treatment strategies of colorectal liver metastases

Scientific Title

Treatment strategies of colorectal liver metastases

Scientific Title:Acronym

Treatment strategies of colorectal liver metastases

Region

Japan


Condition

Condition

colorectal cancer

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Surgical treatment remains the most reliable approach for liver metastases from colorectal cancer. However, complications associated with liver resection can sometimes lead to severe outcomes and patient detriment. Therefore, determining which cases warrant liver resection and the optimal timing for the procedure are critically important. We retrospectively compiled cases of liver metastasis resection from colorectal cancer treated at the Department of General Surgery, Shimane University Hospital (hereinafter referred to as our department). We analyzed factors influencing treatment efficacy and outcomes to inform future clinical research and the development of optimal treatment strategies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Incidence rate of adverse events (adverse reactions)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Individuals diagnosed with colorectal cancer liver metastases via imaging studies (Dynamic CT and MRI examinations) between January 2017 and June 2024.
2) No restrictions on age or gender.
3) No restrictions on the number of liver metastases.
4) Eastern Cooperative Oncology Group Performance Status (ECOG-PS) < 2.
5) Child-Pugh score: 5 to 9 (Grade A~B).

Key exclusion criteria

None

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Takahito
Middle name
Last name Taniura

Organization

Shimane University Faculty of Medicine.

Division name

Department of Digestive and General Surgery

Zip code

693-8501

Address

Enya-cho 89-1, Izumo City, Shimane Prefecture

TEL

0853-20-2232

Email

taniura@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name Takahito
Middle name
Last name Taniura

Organization

Shimane University Faculty of Medicine.

Division name

Department of Digestive and General Surgery

Zip code

693-8501

Address

Enya-cho 89-1, Izumo City, Shimane Prefecture

TEL

0853202232

Homepage URL


Email

taniura@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University Faculty of Medicine.

Institute

Department

Personal name



Funding Source

Organization

Shimane University Faculty of Medicine.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shimane University Hospital Clinical Research Center, Clinical Research Support Division

Address

Enya-cho 89-1, Izumo City, Shimane Prefecture

Tel

0853-20-2515

Email

kenkyu@med.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

島根県


Institutions

Institutions

島根大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 09 Month 26 Day

Date of IRB

2024 Year 09 Month 11 Day

Anticipated trial start date

2024 Year 09 Month 30 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Currently collecting case data


Management information

Registered date

2025 Year 10 Month 15 Day

Last modified on

2025 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067890